Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report

Age-related macular degeneration (AMD) is one of the leading causes of blindness in the United States, affecting approximately 11 million patients. AMD is caused primarily by an upregulation of vascular endothelial growth factor (VEGF). In recent years, aflibercept injections have been used to comba...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Shannon J., Hirani, Anjali, Shahidadpury, Vishal, Solanki, Aum, Halasz, Kathleen, Varghese Gupta, Sheeba, Madow, Brian, Sutariya, Vijaykumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165497/
https://www.ncbi.nlm.nih.gov/pubmed/30208574
http://dx.doi.org/10.3390/biomedicines6030092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165497/
https://www.ncbi.nlm.nih.gov/pubmed/30208574
http://dx.doi.org/10.3390/biomedicines6030092

Ejemplares similares